We are reporting a rare case of bilateral ureteral Non-Hodgkin's lymphoma. A 55-year-old male patient was presented with bilateral loin pain, oliguria and high serum creatinine (8 mg/dl). Non contrast computed tomography revealed bilateral hydroureteronephrosis down to bilateral upper lumbar ureteral soft tissue masses. Drainage of the kidneys by fixation of bilateral indwelling ureteral stents was done. Evaluation of the patient by magnetic resonance imaging revealed bilateral enhancing proximal ureteral lesions. Bilateral diagnostic ureteroscopy revealed bilateral fleshy lesions in the upper lumbar ureter from which was retrieved. The biopsy was positive for poorly differentiated urothelial carcinoma. The patient was managed by right nephroureterectomy. Histopathological evaluation of the radical specimen was highly suspicious for lymphoma. Immunohistochemistry analysis confirmed the presence of diffuse large B-cell lymphoma. The patient received three cycles of multi-agent chemotherapy. Complete remission of the left ureteral lesion was confirmed by magnetic resonance imaging and diagnostic ureteroscopy.
Introduction
Non-Hodgkin's lymphoma (NHL) has a far greater intent to involve extranodal sites compared with Hodgkin's lymphoma (HL). The most commonly affected extranodal sites are the gastrointestinal tract, whereas NHL of the kidney collecting system or the ureter is very rare. Diagnosis and management of this disease have not been unified yet due to the limited number of the reported cases. In our report, an Egyptian male with bilateral diffuse large Bcell lymphoma of the ureter was identified. The patient was treated with surgery and chemotherapy. Supported by the relevant literature, the diagnosis and management of lymphoma of the ureter are discussed in our report.
Case Presentation
In June 2018, a 55-year-old Egyptian male was referred with sub-acute onset bilateral flank pain and oliguria of 1 week duration, Initial renal ultrasonography demonstrated bilateral hydronephrosis which was confirmed by CT scan without contrast ( Figure 1A ), which revealed also evidence of bilateral soft tissue masses in the upper lumbar ureter extending to the renal pelvis and bilateral hilar lymph nodes (Figure1B). Reviewing the medical history of the patient was unremarkable. Physical examination findings were normal, with absence of any clinically evident lymph nodes. In laboratory tests, renal functions tests were affected in the form of high serum creatinine: 17 mg/dl, other laboratory parameters including the complete blood cell (CBC), blood chemistries and the liver function tests were normal. 
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Aiming at managing the acute condition, the patient was initially subjected to one session of hemodialysis, serum creatinine dropped to 8 mg/dl. Then, the patient was transferred to the operative theatre, at which, he was managed by fixation of bilateral double pig tail ureteral stents. Post drainage of the kidneys, recovery of the patient was clearly observed in the form of relief of the flank pain, good urine output and drop of serum creatinine to 1 mg/dl. In order to delineate the nature of bilateral ureteral soft tissue lesions which were demonstrated initially by noncontrast computed tomography, magnetic resonance imaging (MRI) was done and it revealed areas of bilateral soft tissue masses at the upper lumbar ureter (Figure 2A ). This section of the ureteral lesions exhibited an intermediate signal hyperintensity at T1 and T2-WIs. MRI scans also revealed hilar and retrocaval lymphadenopathy ( Figure 2B ). 
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As a case of upper tract urothelial carcinoma (UTUC), the patient was subjected to intervention on the right side, the In November 2018, follow up MRI examination revealed that the left lumbar ureteral tumor disappeared ( Figure 5 ).
The patient was subjected to removal of the left ureteral stent, left ureteropyelography and diagnostic retrograde ureteroscopy revealed free upper end ureter from any growth lesions. Thus far, the follow-up period is five months and the current evaluation is that the patient is in complete remission.
Discussion
Unlike HL, NHL has a greater intent to involve extranodal sites [1] . The most commonly affected extranodal sites are the gastrointestinal tract, testes, ovaries, skin, prostate and central nervous system, whereas NHL of genitourinary tract is rare accounting for less than 5% of extranodal lymphoma [2] . While cases of extranodal isolated ureteral lymphoma have been reported, the most common genitourinary site for extranodal involvement is the kidney [3] . Ureteral involvement by B cell lymphoma is rare, it may be either primary site or more commonly, associated with nodal lymphoma.
A precise search of the PubMed database revealed 21 case reports of malignant lymphoma of the ureter. Detailed information of the reported 21 cases is shown in ( MALT; mucosa-associated lymphoid tissue Table 1 : Malignant lymphoma of the ureter detailed information of the reported 21 cases.
Imaging analysis revealed that the majority of cases had hydronephrosis with no particular imaging characteristics a part from regional lymphadenopathy in 8 cases out of the 21. In most of the cases (14 patients), the diagnosis was initially found to be urothelial carcinoma in the sampled biopsy retrieved by ureteroscopy, for which no immunohistochemistry (IHC) staining was used. For those patients, partial ureterectomy or nephroureterectomy was done. 
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The definitive histopathology of the radical specimens was evident for lymphoma confirmed by IHC analysis. In five cases, IHC was used for the biopsy from the start due to the high suspicion of being lymphoproliferative disorder, evoked by the extensive regional lymphadenopathy. Of all subtypes of NHL, DLBCL and follicular B-cell lymphoma were the most common subtypes to present. In the 14 cases that were diagnosed after surgical intervention by ureterectomy or nephroureterectomy, adjuvant chemotherapy in the form of 4 cycles of R-CHOP protocol (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone) was administered.
The median follow up of the patients was 7 months, ranging between 3 and 15 months. Fifteen patients achieved complete remission of the disease during the follow up period, while, 3 cases developed exacerbation of the disease in the form of retroperitoneal lymphadenopathy which required extra three cycles of R-CHOP chemotherapy.
Overall, 30-50% of NHL patients present with primary extranodal disease. However, the definition of primary extranodal lymphoma is controversial [13] , particularly in patients where nodal and extranodal sites are involved. In the presence of incidental ureteral lymphoma, it is difficult to assess whether it is primary or secondary due to mass effect or infiltration from surrounding lymphadenopathy. Although distinguishing whether ureteral lymphomas are primary or caused by metastasis is difficult, in our report, it is important that the ureter was most likely the primary location of the disease due to the presence of small regional lymph node and absence of generalized lymph nodes.
Diagnosis is a challenge; primarily due to the lack of imaging characteristics in CT [5] or MRI [4] , and, secondarily due to the rare incidence of this peculiar pathology in the ureter. In most of the cases, the biopsy retrieved by ureteroscopy is a small one and revealed usually plasmacytoid features as the cells have an eccentric nucleus and eosinophilic cytoplasm. Plasmacytoid features have be seen in a variety of tumors affecting the genitourinary tract, which include urothelial carcinoma, large cell lymphoma, plasmacytoma, malignant melanoma, paraganglioma, neuroendocrine carcinoma, and rhabdomyosarcoma [14] . The use of (IHC) markers of cytokeratin, CD45, CD 20 and CD3 confirms the diagnosis of lymphoma. The utility of CD45 with panels of antibodies to cytokeratin and S100 protein is helpful in the resolution of whether or not a polygonal or small cell undifferentiated lesion is a carcinoma, lymphoma, or melanoma [15] . Chemotherapy is the treatment of choice, especially in controlling systemic disease in evident nodal disease with ureteral involvement [16] . Prognosis of primary extranodal lymphoma is, to some extent, less favorable than the primary nodal disease with extranodal extension, mostly due to the earlier diagnosis and proper management by early chemotherapy in nodal disease group [17] . Primary ureteral lymphoma is still carrying the risk of kidney loss due to the management of the disease as upper tract urothelial carcinoma, with subsequent burden of chemotherapy and its nephrotoxic effect on the remaining solitary kidney.
Conclusion
We reported a unique case of primary bilateral ureteral DLBCL, presenting as bilateral ureteral soft tissue lesions.
Although rare, lymphoma of the ureter should be included in the differential diagnosis of ureteral mass or idiopathic stricture. Immunohistochemistry (IHC) staining is the gold standard tool for histopathological diagnosis.
